Information TechnologyIT - SoftwareComputers - Software & Consulting

Zensar Technologies Ltd

Showing the latest 10 filings. Sign in to filter or browse the full history.
10 of 81 filings·Updated 10 Oct 2026
Showing 10 of 81 filings.
10 Oct 20262 filings
Company UpdateNewspaper Publication

Newspaper Advertisement in respect to a special window opened for lodgement of transfer and dematerialization request(s)

No brief for this announcement.Newspaper publications aren’t summarised. View the original using the link below
Filed 17:34View Source
Company UpdateCopy of Newspaper Publication

Zensar Technologies Limited has informed the Exchange about Copy of Newspaper Publication in respect to a special window opened for lodgementof transfer and dematerialization (demat) request(s)

No brief for this announcement.Newspaper publications aren’t summarised. View the original using the link below
Filed 15:59View Source
8 Oct 20261 filing
Company UpdateCertificate under SEBI (Depositories and Participants) Regulations, 2018

Zensar Technologies Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018

No brief for this announcement.This type of announcement aren’t summarised. View the original using the link below
Filed 16:21View Source
7 Oct 20261 filing
Company UpdateAllotment of ESOP / ESPS

Intimation about allotment of Equity shares by Nomination and Remuneration Committee

No brief for this announcement.This type of announcement aren’t summarised. View the original using the link below
Filed 16:12View Source
30 Sept 20261 filing
Insider Trading / SASTClosure of Trading Window

Zensar Technologies Limited — Trading Window closed from October 1, 2026 for the Unaudited (Standalone and Consolidated) Financial Results for the quarter and half year ended September 30, 2026; window shall open 48 hours after declaration of the results and other matters, if any.

Zensar Technologies Limited — Trading Window closed from October 1, 2026 for the Unaudited (Standalone and Consolidated) Financial Results for the quarter and half year ended September 30, 2026; window shall open 48 hours after declaration of the results and other matters, if any.

Filed 16:28View Source
31 Aug 20261 filing
Company UpdateCredit Rating

ICRA reaffirmed AA+/A1+ ratings for Rs 191 crore facilities with Stable outlook

Rating Action Details

  • Long-term/short-term fund-based/non-fund-based facilities rated AA+/A1+; reaffirmed for Rs 191 crore.
  • Total facilities rated: Rs 191 crore.
  • Rating agency: ICRA Limited.
  • Outlook: Stable.
  • Action: Reaffirmed; no change to rating.
  • Rationale: Not disclosed in rating letter.
  • Surveillance due within one year; ratings may be revised on new information.
  • Bank limits rated total Rs 191 crore across multiple banks.
Filed 16:50View Source
24 Aug 20262 filings
Company UpdateOptions to purchase securities

Zensar approves ESOP allotment; issued capital increases on Aug 24, 2026

Capital / Securities

  • Aug 24, 2026: Nomination and Remuneration Committee approved allotment of 25,691 equity shares on ESOP exercise.
  • Consequently, on Aug 24, 2026, issued capital increased to Rs 455,161,426 comprising 227,580,713 equity shares.
Filed 19:24View Source
Company UpdateAllotment of ESOP / ESPS

Intimation about allotment of Equity Shares by the Nomination and Remuneration Committee

No brief for this announcement.This type of announcement aren’t summarised. View the original using the link below
Filed 19:12View Source
14 Aug 20262 filings
Company UpdateGeneral

M3BI merger with Zensar Technologies Inc. becomes effective Sep 1, 2026; Bridgeview filings completed

US subsidiary mergers

  • M3BI LLC merger with Zensar Technologies Inc. becomes effective on September 1, 2026.
  • Bridgeview Life Sciences LLC merger filings completed with Zensar Technologies Inc.
  • All requisite local filings for both mergers completed; post-merger filings remain in process.
  • Intimation of M3BI merger received at 1:43 a.m. IST on August 14, 2026.
Filed 13:17View Source
Company UpdateGeneral

Mergers of Bridgeview Life Sciences LLC and M3BI LLC with Zensar Technologies Inc. filings completed; M3BI effective Sept 1, 2026

US subsidiary mergers status

  • Mergers of Bridgeview Life Sciences LLC and M3BI LLC with Zensar Technologies Inc. have completed requisite filings.
  • M3BI LLC merger with Zensar Technologies Inc. becomes effective from September 1, 2026.
  • Bridgeview Life Sciences LLC merger filings completed; post-merger and consequential filings remain in process.
Filed 13:16View Source
Showing 10 of 81 filings